Abstract
We report a case of proton magnetic resonance spectroscopy (MRS) of hemangioblastoma in a 56-yearold man with a history of hyperlipidemia who was suffering from an equilibrium disorder. Proton MRS revealed a high mobile lipids (Lip) peak between 0.9 and 1.4 ppm, which was compatible with histologically proven lipids in the tumor. No lactate peak was recognized. The creatine/phosphocreatine peak was low. Choline-containing compounds were increased. The N-acetylaspartate peak was absent, which indicated that the tumor is of nonneurogenic origin. Combined with the absence of the necrotic component on magnetic resonance imaging, this Lip peak on proton MRS could be the characteristic pattern of hemangioblastoma. These unique results of proton MRS can play an important role in the differential diagnosis of intracranial hemangioblastoma. However, further investigations are required to establish the typical characteristics of proton MRS of hemangioblastoma.
Similar content being viewed by others
References
Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, et al. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 1997;28:54–63.
Vatsal DK, Husain M, Husain N, Chawla S, Roy R, Gupta RK. Cerebellar hemangioblastoma simulating arachnoid cyst on imaging and surgery. Neurosurg Rev 2002;25:107–109.
Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79–93.
Isobe T, Matsumura A, Anno I, Kawamura H, Muraishi H, Umeda T, et al. Effect of J coupling and T2 relaxation in assessing of methyl lactate signal using PRESS sequence MR spectroscopy. Jpn J Med Phys 2005;25:68–74.
Prichard JW. What the clinician can learn from MRS lactate measurements. NMR Biomed 1991;4:99–102.
Chaudhry AP, Montes M, Cohn GA. Ultrastructure of cerebellar hemangioblastoma. Cancer 1978;42:1834–1850.
Falini A, Calabrese G, Origgi D, Lipari S, Triulzi F, Losa M, et al. Proton magnetic resonance spectroscopy and intracranial tumors: clinical perspectives. J Neurol 1996;243:706–714.
Qi ZG, Li YX, Wang Y, Geng DY, Li KC, Shen TZ, et al. Lipid signal in evaluation of intracranial meningiomas. Chin Med J (Engl) 2008;121:2415–2419.
Cho YD, Choi GH, Lee SP, Kim JK. 1H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 2003;21:663–672.
Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 1991;4:47–52.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Isobe, T., Yamamoto, T., Akutsu, H. et al. Proton magnetic resonance spectroscopy findings of hemangioblastoma. Jpn J Radiol 28, 318–321 (2010). https://doi.org/10.1007/s11604-010-0421-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-010-0421-5